Precision Gene Therapy · Rare Disease
Arcivus
Building patient-specific gene therapies for rare neurological disease — starting with a single mutation, scaling to a platform.
1 in 500,000
Prevalence
0 Approved Therapies
Disease-modifying treatments
~60% Symptom Ceiling
Best pharmacological outcome